Navigation Links
ADVENTRX Announces Establishment of Regulatory Advisory Board
Date:4/9/2012

ted in approvals.

Prior to serving as an independent consultant, Dr. Hepburn served in a number of senior roles, most recently as Senior Vice President, Drug Development, at Santarus, Inc., a specialty biopharmaceutical company in San Diego, focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists. At Santarus, Dr. Hepburn was responsible for the establishment of the team responsible for drug development, clinical research and regulatory affairs, which led to the approval of the Zegerid products. Prior to joining Santarus, she served in a variety of senior roles, including Vice President of Clinical Development at La Jolla Pharmaceutical Company, Director of Immunology Clinical Research and head of the infliximab development team at Centocor, Inc., and Head of Inflammation, Bone and Allergy Clinical Research, Executive Director of Anti-inflammatory Research and Director of Regulatory Affairs at Novartis.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on developing proprietary product candidates.  The Company's lead product candidate is ANX-188, a rheologic, antithrombotic and cytoprotective agent that improves microvascular blood flow and has potential application in treating a wide range of diseases and conditions, such as complications arising from sickle cell disease.  We also are developing ANX-514, a novel, detergent-free formulation of the chemotherapy drug docetaxel.  More information can be found on the Company's web site at www.adventrx.com.

Forward Looking Statements
ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that are based on ADVENTRX's current expectations and assumptions. Such forward-looking statements include, but are n
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. ADVENTRX Announces Appointment of Senior Vice President, Commercial
2. ADVENTRX Pharmaceuticals Reports Second Quarter Financial Results
3. ADVENTRX to Hold Second Quarter Results and Business Update Conference Call on August 12
4. ADVENTRX Pharmaceuticals Announces Financing
5. ADVENTRX Pharmaceuticals Announces Plans for Remainder of 2009
6. ADVENTRX Pharmaceuticals Announces Closing of Financing
7. ADVENTRX Pharmaceuticals Announces Financing
8. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results
9. ADVENTRX Announces Further Cost-Cutting Measures
10. ADVENTRX Provides Update on Strategic Transaction Process
11. ADVENTRX Announces Further Cost-Cutting Measures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... 20, 2014 MediVet America ... a groundbreaking surgery at the specialized Wolvega Horse Clinic. ... digital flexor tendon was ruptured 90% and her deep ... is a death sentence for a horse. , The ... cell treatments . This revolutionary regenerative option for ...
(Date:9/19/2014)... San Jose, California (PRWEB) September 19, 2014 ... – Nanotechnology and its potential to revolutionize the ... government agencies, multinational corporations and small start-ups. The ... government funded research projects largely due to the ... capital investments. Government budgets earmarked for this evolving ...
(Date:9/19/2014)... BioTech News Coverage: Progress made ... of studies and trials.  Companies in focus are: GenSpera ... LLY ), Gilead Sciences Inc. (NASDAQ: ... and Arena Pharmaceuticals Inc. (NASDAQ: ARNA) GenSpera, ... for the treatment of cancer, announced that the United ...
(Date:9/19/2014)... , September 19, 2014 The ... Spain , available today on PharmaBoardroom.com ... the Eurozone crisis that rocked the Spanish economy in 2009, ... Spanish pharma community has remained pragmatic in times of trouble. ... is still the fifth biggest European market, and the general ...
Breaking Biology Technology:World’s first tendon replacement using Nanofiber and activated MediVet Stem Cell Fraction 2World’s first tendon replacement using Nanofiber and activated MediVet Stem Cell Fraction 3Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 2Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 3Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 4Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 2Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 3Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 4Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 5Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 6Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 7PharmaBoardroom Releases New Spain Pharmaceuticals Report 2PharmaBoardroom Releases New Spain Pharmaceuticals Report 3
... April 23 ImaRx Therapeutics,Inc. (Nasdaq: IMRX ... an agreement,with Abbott Laboratories pursuant to which it ... promissory note with Abbott issued in,connection with its ... to,the urokinase assets, including the remaining inventory of ...
... PHILADELPHIA, April 23 BioNanomatrix, Inc. today,announced that ... honored at the,14th Annual Ben Franklin Emerging Business ... Management Team category, competing with a,strong group of ... executive officer Dr. Michael Boyce-Jacino accepted the,award on ...
... Calif., April 23 SectorWatch.biz announces the,availability ... news and driving,markets today within the biotechnology ... on the aforementioned equities and the,opportunity for ... on the,subject and sector., Investors can ...
Cached Biology Technology:ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase 2ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase 3BioNanomatrix Named 'Best Management Team' at the 2008 Ben Franklin Emerging Business Awards 2SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT 2SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT 3
(Date:9/18/2014)... 2014 -- Arizona turned its newborn screening program into a ... months, earning it the first-ever Newborn Screening Quality Award from ... presented Will Humble, M.P.H., Arizona,s Department of Health Services director, ... Humble established a policy of full transparency for the length ... samples to the lab for analysis, and set a target ...
(Date:9/18/2014)... in the eastern Mediterranean Sea pose a major threat ... to expand as the climate warms, a new study ... led by Dr Adriana Vergs of UNSW Australia and ... Studies in Spain, is published in the Journal ... than 1000 kilometres of coastline in Turkey and Greece, ...
(Date:9/18/2014)... fish world, are the ideal animal in which to ... from the ocean into tens of thousands of freshwater ... their skeleton to adapt to the new environment. , ... now have turned up one of the genes that ... in that gene,s regulation in a freshwater population is ...
Breaking Biology News(10 mins):March of Dimes honors Arizona with first-ever newborn screening award 2March of Dimes honors Arizona with first-ever newborn screening award 3Tropical fish a threat to Mediterranean Sea ecosystems 2Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation 2Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation 3
... German . , What is the role of ... mean for the nutrition and balance of a forest ecosystem? How ... even in mobile internet access? How do the modern arts experience, ... for the interpretation of artistic creations in general? These are just ...
... May 2012 Fifty-five life scientists from Europe and ... their excellence in research. Forty-eight of the researchers are ... Argentina, Australia, South Korea and the United States join ... almost 1,550 life scientists in the international scientific community. ...
... It was all too evident during the Dust ... dry, unprotected topsoil. Now a new study has uncovered ... Not only can it carry away soil particles, but ... contaminants, and recycle nutrients. Using a powerful DNA ...
Cached Biology News:DFG establishes 10 new priority programs 2DFG establishes 10 new priority programs 3Agricultural bacteria: Blowing in the wind 2Agricultural bacteria: Blowing in the wind 3
Complement factor B (human)...
... JNK (c-Jun NH2-terminal kinase) signal transduction ... MAP kinase pathways in mammals. JNK ... environmental stress, is associated with the ... is implicated in the immune response, ...
... mid-, near- and far-infrared range FT-IR spectrometers ... in their class. Yet all this comes ... Highest-energy throughput: Having a larger and ... to other conventional FT-IRs provides 300%,larger solid ...
... HORIBA Jobin Yvons Protein 295 ex ... a protein sample in only a few ... the amino acids tyrosine and tryptophan, the ... powerful NanoLED-17, a pulsed diode emitting 295 ...
Biology Products: